Cilo Cybin Holdings (JSE:CCC) Research & Development: R0.00 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:CCC Cilo Cybin Holdings Ltd JSE:CCC
7 GF Score
Price R0.78
! 1 Warning Sign
View Full Analysis

What is Cilo Cybin Holdings Research & Development?

Cilo Cybin Holdings JSE:CCC 7 Research & Development is R0.00 Mil as of Sep. 2025. GuruFocus rates JSE:CCC with a GF Score™ of 7/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cilo Cybin Holdings's Research & Development for the six months ended in Sep. 2025 was R0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was R0.00 Mil.

Cilo Cybin Holdings  (JSE:CCC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cilo Cybin Holdings Research & Development Related Terms

Cilo Cybin Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Cilo Cybin Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cilo Cybin Holdings Research & Development Chart

Cilo Cybin Holdings Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Research & Development
0.00 0.00 0.00 0.00

Cilo Cybin Holdings Semi-Annual Data
Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
JSE:CCC
7GF Score
Cilo Cybin Holdings Ltd JSE:CCC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cilo Cybin Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was R0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R0.00 Mil mean?
Cilo Cybin Holdings (JSE:CCC) has a Research & Development of R0.00 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on Cilo Cybin Holdings and its competitors.
Is Cilo Cybin Holdings' Research & Development too high?
Cilo Cybin Holdings' current Research & Development is R0.00 Mil. Overall, Cilo Cybin Holdings has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Cilo Cybin Holdings' Research & Development compare to ZTS and UTHR?
Cilo Cybin Holdings' Research & Development of R0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cilo Cybin Holdings and its competitors. Cilo Cybin Holdings's current Research & Development is R0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cilo Cybin Holdings stock overvalued right now?
Cilo Cybin Holdings (JSE:CCC) has a current Research & Development of R0.00 Mil. The current Research & Development is R0.00 Mil. Cilo Cybin Holdings' overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cilo Cybin Holdings (JSE:CCC), the current Research & Development is R0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cilo Cybin Holdings Business Description

Address 7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157
Cilo Cybin Holdings Ltd is engaged in identifying viable investments in Biotech, Biohacking and Pharmaceutical businesses. It offers products and services in the medical cannabis sector.
7GF Score

Get the complete analysis for JSE:CCC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.78
Price